English
Insider transactions
EDGARQuest Diagnostics Incorporated
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 41 transactions, 217,384 shares
- Sum of shares × price per share: 47,360,613.9362
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 167
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 Filed 2026-11-16 | Deppe Michael J Officer: SVP, Corp. Controller CAO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 6,261 | 95.795 | 599,772.495Derived: shares × price per share. Exact value 599772.495. | 41,464 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000127 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Deppe Michael J Officer: SVP, Corp. Controller CAO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,261 | 260.17 | 1,628,924.37Derived: shares × price per share. Exact value 1628924.37. | 35,203 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000127 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Deppe Michael J Officer: SVP, Corp. Controller CAO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 5,515 | 103.57 | 571,188.55Derived: shares × price per share. Exact value 571188.55. | 40,718 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000127 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Deppe Michael J Officer: SVP, Corp. Controller CAO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,515 | 260.17 | 1,434,837.55Derived: shares × price per share. Exact value 1434837.55. | 35,203 | Direct (D) | Yes | F1, F2
| Open filing 0001022079-26-000127 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Deppe Michael J Officer: SVP, Corp. Controller CAO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 6,261 | 95.795 | 599,772.495Derived: shares × price per share. Exact value 599772.495. | 0 | Direct (D) | Yes | F1, F4
| Open filing 0001022079-26-000127 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Deppe Michael J Officer: SVP, Corp. Controller CAO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 5,515 | 103.57 | 571,188.55Derived: shares × price per share. Exact value 571188.55. | 0 | Direct (D) | Yes | F1, F4
| Open filing 0001022079-26-000127 Read from the filing’s XML Dispute this row |
| 2026-11-09 Filed 2026-11-12 | Plewman Patrick Officer: SVP for Diagnostic Services | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 4,274 | 127.725 | 545,896.65Derived: shares × price per share. Exact value 545896.650. | 19,608 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000125 Read from the filing’s XML Dispute this row |
| 2026-11-09 Filed 2026-11-12 | Plewman Patrick Officer: SVP for Diagnostic Services | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,274 | 257.34 | 1,099,871.16Derived: shares × price per share. Exact value 1099871.16. | 15,334 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000125 Read from the filing’s XML Dispute this row |
| 2026-11-09 Filed 2026-11-12 | Plewman Patrick Officer: SVP for Diagnostic Services | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 6,793 | 127.805 | 868,179.365Derived: shares × price per share. Exact value 868179.365. | 22,127 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000125 Read from the filing’s XML Dispute this row |
| 2026-11-09 Filed 2026-11-12 | Plewman Patrick Officer: SVP for Diagnostic Services | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,793 | 257.34 | 1,748,110.62Derived: shares × price per share. Exact value 1748110.62. | 15,334 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000125 Read from the filing’s XML Dispute this row |
| 2026-11-09 Filed 2026-11-12 | Plewman Patrick Officer: SVP for Diagnostic Services | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 650 | 257.34 | 167,271Derived: shares × price per share. Exact value 167271.00. | 14,684 | Direct (D) | Yes | F2
| Open filing 0001022079-26-000125 Read from the filing’s XML Dispute this row |
| 2026-11-09 Filed 2026-11-12 | Plewman Patrick Officer: SVP for Diagnostic Services | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 4,274 | 127.725 | 545,896.65Derived: shares × price per share. Exact value 545896.650. | 0 | Direct (D) | Yes | F1, F3
| Open filing 0001022079-26-000125 Read from the filing’s XML Dispute this row |
| 2026-11-09 Filed 2026-11-12 | Plewman Patrick Officer: SVP for Diagnostic Services | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 6,793 | 127.805 | 868,179.365Derived: shares × price per share. Exact value 868179.365. | 3,397 | Direct (D) | Yes | F1, F3
| Open filing 0001022079-26-000125 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | DELANEY MARK E Officer: SVP Chief Commercial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,615 | 0 | — | 12,975 | Direct (D) | No | F1
| Open filing 0001022079-26-000121 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 4,827 | 0 | — | 71,949 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 22,105 | 121.805 | 2,692,499.525Derived: shares × price per share. Exact value 2692499.525. | 94,054 | Direct (D) | Yes | F2
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,818 | 245.4519 | 937,135.3542Derived: shares × price per share. Exact value 937135.3542. | 90,236 | Direct (D) | Yes | F2, F3
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,990 | 246.2649 | 1,475,126.751Derived: shares × price per share. Exact value 1475126.7510. | 84,246 | Direct (D) | Yes | F2, F4
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,151 | 246.9835 | 284,278.0085Derived: shares × price per share. Exact value 284278.0085. | 83,095 | Direct (D) | Yes | F2, F5
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,358 | 248.3838 | 585,689.0004Derived: shares × price per share. Exact value 585689.0004. | 80,737 | Direct (D) | Yes | F2, F6
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,004 | 249.4035 | 749,208.114Derived: shares × price per share. Exact value 749208.1140. | 77,733 | Direct (D) | Yes | F2, F7
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,877 | 250.4882 | 720,654.5514Derived: shares × price per share. Exact value 720654.5514. | 74,856 | Direct (D) | Yes | F2, F8
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,907 | 251.2386 | 730,350.6102Derived: shares × price per share. Exact value 730350.6102. | 71,949 | Direct (D) | Yes | F2, F9
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Doherty Catherine T. Officer: Executive Vice President | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 22,105 | 121.805 | 2,692,499.525Derived: shares × price per share. Exact value 2692499.525. | 0 | Direct (D) | Yes | F2, F11
| Open filing 0001022079-26-000122 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Ramachandran Subu Officer: SVP, Regional Businesses | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 352 | 0 | — | 2,832 | Direct (D) | No | F1
| Open filing 0001022079-26-000123 Read from the filing’s XML Dispute this row |
| 2026-11-03 Filed 2026-11-05 | Ramachandran Subu Officer: SVP, Regional Businesses | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,386 | 0 | — | 1,386 | Direct (D) | No | F2
| Open filing 0001022079-26-000123 Read from the filing’s XML Dispute this row |
| 2026-10-26 Filed 2026-10-28 | PFEIFFER GARY M Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,203 | 243 | 292,329Derived: shares × price per share. Exact value 292329. | 29,802 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000118 Read from the filing’s XML Dispute this row |
| 2026-10-21 Filed 2026-10-23 | Plewman Patrick Officer: SVP for Diagnostic Services | LSmall acquisition under Rule 16a-6 | Acquired (A) | 41 | 235.94 | 9,673.54Derived: shares × price per share. Exact value 9673.54. | 15,334 | Direct (D) | No | F1
| Open filing 0001022079-26-000111 Read from the filing’s XML Dispute this row |
| 2026-10-21 Filed 2026-10-23 | Gregg Vicky B Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 63 | 235.939 | 14,864.157Derived: shares × price per share. Exact value 14864.157. | 18,449 | Direct (D) | No | F1
| Open filing 0001022079-26-000114 Read from the filing’s XML Dispute this row |
| 2026-10-21 Filed 2026-10-23 | SAMAD SAM Officer: Executive Vice President CFO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 90 | 235.939 | 21,234.51Derived: shares × price per share. Exact value 21234.510. | 33,568 | Direct (D) | No | F1
| Open filing 0001022079-26-000115 Read from the filing’s XML Dispute this row |
| 2026-10-21 Filed 2026-10-23 | CARTER ROBERT B Director | LSmall acquisition under Rule 16a-6 | Acquired (A) | 10 | 235.93 | 2,359.3Derived: shares × price per share. Exact value 2359.30. | 3,874 | Direct (D) | No | F1
| Open filing 0001022079-26-000116 Read from the filing’s XML Dispute this row |
| 2026-10-21 Filed 2026-10-23 | KUPPUSAMY KARTHIK Officer: SVP, Clinical Solutions | LSmall acquisition under Rule 16a-6 | Acquired (A) | 33 | 235.944 | 7,786.152Derived: shares × price per share. Exact value 7786.152. | 13,619 | Direct (D) | No | F1, F2
| Open filing 0001022079-26-000113 Read from the filing’s XML Dispute this row |
| 2026-10-21 Filed 2026-10-23 | Lassiter Wright III Director | LSmall acquisition under Rule 16a-6 | Acquired (A) | 6 | 235.959 | 1,415.754Derived: shares × price per share. Exact value 1415.754. | 10,329 | Direct (D) | No | F1
| Open filing 0001022079-26-000112 Read from the filing’s XML Dispute this row |
| 2026-10-21 Filed 2026-10-23 | DELANEY MARK E Officer: SVP Chief Commercial Officer | LSmall acquisition under Rule 16a-6 | Acquired (A) | 25 | 235.941 | 5,898.525Derived: shares × price per share. Exact value 5898.525. | 10,360 | Direct (D) | No | F1
| Open filing 0001022079-26-000109 Read from the filing’s XML Dispute this row |
| 2026-10-21 Filed 2026-10-23 | MAIN TIMOTHY L Director | LSmall acquisition under Rule 16a-6 | Acquired (A) | 18 | 235.937 | 4,246.866Derived: shares × price per share. Exact value 4246.866. | 22,478 | Direct (D) | No | F1
| Open filing 0001022079-26-000110 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-02 | WENTWORTH TIMOTHY C Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 135 | 0 | — | 477 | Direct (D) | No | F1
| Open filing 0001022079-26-000090 Read from the filing’s XML Dispute this row |
| 2026-09-01 Filed 2026-09-03 | Davis J. E. Director · Officer: CEO and President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,000 | 242.72 | 2,427,200Derived: shares × price per share. Exact value 2427200.00. | 122,423 | Direct (D) | Yes | F1
| Open filing 0001599837-26-000007 Read from the filing’s XML Dispute this row |
| 2026-08-28 Filed 2026-08-31 | PREVOZNIK MICHAEL E Officer: SVP General Counsel | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 22,677 | 112.17 | 2,543,679.09Derived: shares × price per share. Exact value 2543679.09. | 60,234 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000089 Read from the filing’s XML Dispute this row |
| 2026-08-28 Filed 2026-08-31 | PREVOZNIK MICHAEL E Officer: SVP General Counsel | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 16,010 | 242.8755 | 3,888,436.755Derived: shares × price per share. Exact value 3888436.7550. | 44,224 | Direct (D) | Yes | F1, F2
| Open filing 0001022079-26-000089 Read from the filing’s XML Dispute this row |
| 2026-08-28 Filed 2026-08-31 | PREVOZNIK MICHAEL E Officer: SVP General Counsel | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,237 | 243.6275 | 1,519,504.7175Derived: shares × price per share. Exact value 1519504.7175. | 37,987 | Direct (D) | Yes | F1, F3
| Open filing 0001022079-26-000089 Read from the filing’s XML Dispute this row |
| 2026-08-28 Filed 2026-08-31 | PREVOZNIK MICHAEL E Officer: SVP General Counsel | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 430 | 244.5148 | 105,141.364Derived: shares × price per share. Exact value 105141.3640. | 37,557 | Direct (D) | Yes | F1, F4
| Open filing 0001022079-26-000089 Read from the filing’s XML Dispute this row |
| 2026-08-28 Filed 2026-08-31 | PREVOZNIK MICHAEL E Officer: SVP General Counsel | GBona fide gift | Disposed (D) | 1,000 | 0 | — | 36,557 | Direct (D) | Yes | F5
| Open filing 0001022079-26-000089 Read from the filing’s XML Dispute this row |
| 2026-08-28 Filed 2026-08-31 | PREVOZNIK MICHAEL E Officer: SVP General Counsel | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 22,677 | 112.17 | 2,543,679.09Derived: shares × price per share. Exact value 2543679.09. | 0 | Direct (D) | Yes | F1, F7
| Open filing 0001022079-26-000089 Read from the filing’s XML Dispute this row |
| 2026-07-28 Filed 2026-07-29 | DELANEY MARK E Officer: SVP Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,600 | 235.18 | 376,288Derived: shares × price per share. Exact value 376288.00. | 10,335 | Direct (D) | Yes | F1
| Open filing 0001022079-26-000087 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-27 | MAIN TIMOTHY L Director | LSmall acquisition under Rule 16a-6 | Acquired (A) | 21 | 206.81 | 4,343.01Derived: shares × price per share. Exact value 4343.01. | 22,460 | Direct (D) | No | F1
| Open filing 0001022079-26-000082 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-27 | Lassiter Wright III Director | LSmall acquisition under Rule 16a-6 | Acquired (A) | 6 | 206.813 | 1,240.878Derived: shares × price per share. Exact value 1240.878. | 10,323 | Direct (D) | No | F1
| Open filing 0001022079-26-000080 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-27 | SAMAD SAM Officer: Executive Vice President CFO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 102 | 206.807 | 21,094.314Derived: shares × price per share. Exact value 21094.314. | 33,478 | Direct (D) | No | F1, F2
| Open filing 0001022079-26-000081 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-27 | Gregg Vicky B Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 72 | 206.808 | 14,890.176Derived: shares × price per share. Exact value 14890.176. | 18,386 | Direct (D) | No | F1
| Open filing 0001022079-26-000084 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-27 | CARTER ROBERT B Director | LSmall acquisition under Rule 16a-6 | Acquired (A) | 11 | 206.804 | 2,274.844Derived: shares × price per share. Exact value 2274.844. | 3,864 | Direct (D) | No | F1
| Open filing 0001022079-26-000085 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-27 | KUPPUSAMY KARTHIK Officer: SVP, Clinical Solutions | LSmall acquisition under Rule 16a-6 | Acquired (A) | 37 | 206.807 | 7,651.859Derived: shares × price per share. Exact value 7651.859. | 13,557 | Direct (D) | No | F1, F2
| Open filing 0001022079-26-000086 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
Showing 1–31 of 31
| Member | Transaction date | Type | Amount | Owner | Report |
|---|---|---|---|---|---|
| Hon. Carol Devine Miller (WV01) | 2025-03-10 | Sale | $15,001 - $50,000 | 2026-08-13 | |
| Hon. Julie Johnson (TX32) | 2025-10-30 | Sale | $1,001 - $15,000 | JT | 2026-08-05 |
| Hon. Julie Johnson (TX32) | 2025-10-30 | Purchase | $1,001 - $15,000 | JT | 2026-08-05 |
| Hon. Julia Letlow (LA05) | 2025-04-28 | Purchase | $1,001 - $15,000 | 2026-01-13 | |
| Hon. Julia Letlow (LA05) | 2025-07-24 | Sale | $1,001 - $15,000 | 2026-01-13 | |
| Hon. Julie Johnson (TX32) | 2025-11-03 | Sale | $1,001 - $15,000 | JT | 2025-12-11 |
| Hon. Gilbert Cisneros (CA31) | 2025-01-24 | Sale (partial) | $1,001 - $15,000 | 2025-02-11 | |
| Hon. Earl Blumenauer (OR03) | 2024-04-04 | Sale | $1,001 - $15,000 | SP | 2024-05-04 |
| Hon. Carol Devine Miller (WV03) | 2022-11-14 | Purchase | $1,001 - $15,000 | 2022-12-13 | |
| Hon. Kathy Manning (NC06) | 2022-08-03 | Sale | $1,001 - $15,000 | JT | 2022-09-14 |
| Hon. Carol Devine Miller (WV03) | 2021-07-28 | Purchase | $15,001 - $50,000 | SP | 2022-09-02 |
| Hon. Kathy Manning (NC06) | 2022-07-20 | Purchase | $1,001 - $15,000 | JT | 2022-08-10 |
| Hon. Earl Blumenauer (OR03) | 2022-02-24 | Purchase | $1,001 - $15,000 | 2022-04-01 | |
| Hon. Earl Blumenauer (OR03) | 2022-03-14 | Sale | $1,001 - $15,000 | 2022-04-01 | |
| Hon. Sara Jacobs (CA53) | 2021-04-09 | Sale | $50,001 - $100,000 | 2021-05-28 | |
| Hon. Dean Phillips (MN03) | 2020-06-01 | Sale (partial) | $1,001 - $15,000 | 2020-07-07 | |
| Hon. Dean Phillips (MN03) | 2020-04-02 | Sale (partial) | $1,001 - $15,000 | 2020-05-07 | |
| Hon. Earl Blumenauer (OR03) | 2020-03-02 | Purchase | $1,001 - $15,000 | 2020-04-16 | |
| Hon. Dean Phillips (MN03) | 2020-02-10 | Sale (partial) | $1,001 - $15,000 | 2020-03-12 | |
| Hon. Dean Phillips (MN03) | 2020-01-17 | Purchase | $1,001 - $15,000 | 2020-02-07 | |
| Hon. Dean Phillips (MN03) | 2019-07-31 | Purchase | $1,001 - $15,000 | 2019-08-21 | |
| Hon. Dean Phillips (MN03) | 2019-05-03 | Purchase | $1,001 - $15,000 | 2019-06-13 | |
| Hon. Dean Phillips (MN03) | 2019-04-04 | Sale (partial) | $1,001 - $15,000 | 2019-05-21 | |
| Hon. Gilbert Cisneros (CA39) | 2019-03-14 | Purchase | $1,001 - $15,000 | 2019-04-16 | |
| Hon. Dean Phillips (MN03) | 2019-02-04 | Purchase | $1,001 - $15,000 | 2019-03-21 | |
| Hon. K. Michael Conaway (TX11) | 2016-09-12 | Sale | $1,001 - $15,000 | SP | 2016-10-12 |
| Hon. Lois Frankel (FL22) | 2016-06-20 | Sale | $1,001 - $15,000 | 2016-08-16 | |
| Hon. Lois Frankel (FL22) | 2015-05-27 | Sale | $1,001 - $15,000 | 2015-06-19 | |
| Mr. Richard L. Hanna (NY22) | 2014-10-15 | Sale | $1,001 - $15,000 | JT | 2014-11-11 |
| Mr. Richard L. Hanna (NY22) | 2013-12-27 | Sale | $100,001 - $250,000 | 2014-01-15 | |
| Mr. Richard L. Hanna (NY22) | 2013-12-30 | Sale | $1,001 - $15,000 | 2014-01-15 |
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| STATE STREET CORPORATION COMMON STOCK | 5 | 5,563,421.00 | 09/30/2026 Filed 2026-11-10 | SCHEDULE 13G | Open filing 0000093751-26-000709 Dispute this row |
| T. Rowe Price Associates, Inc. COMMON STOCK | 4.9 | 5,428,244 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000080255-26-000528 Dispute this row |
| Vanguard Capital Management Common Stock | 7.53 | 8,274,567 | 03/31/2026 Filed 2026-04-30 | SCHEDULE 13G | Open filing 0002100119-26-001044 Dispute this row |
| Vanguard Portfolio Management Common Stock | 5.54 | 6,096,629 | 03/31/2026 Filed 2026-04-29 | SCHEDULE 13G | Open filing 0002100121-26-000570 Dispute this row |
| The Vanguard Group Common Stock | 0 | 0 | 03/13/2026 Filed 2026-03-27 | SCHEDULE 13G/AAmendment 13 | Open filing 0000102909-26-002167 Dispute this row |
| T. Rowe Price Associates, Inc. COMMON STOCK | 6.5 | 7,209,622 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000080255-25-000562 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,700,931 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 117,313 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.